COMP-angiopoietin-1 accelerates bone formation during distraction osteogenesis

Bone

Volumn 46, Issue 5, 2010, Pages 1442-1448

  Park, Byung Hyun ^a   Yoon, Sun Jung ^a   Jang, Kyu Yun ^a   Kim, Mi Ran ^a   Lee, Hyung Seok ^a   Kim, Ki Bum ^a   Park, Hyuk ^a   Lee, Sang Yong ^a   Park, Ho Sung ^a   Lim, Seok Tae ^a   Song, Kyung Jin ^a   Kim, Jung Ryul ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Angiogenesis; COMP Ang1; Distraction osteogenesis; Tibia

Indexed keywords

ANGIOGENIC FACTOR; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; BONE SIALOPROTEIN; BOVINE SERUM ALBUMIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; OSTEOPONTIN; OSTERIX; RECOMBINANT CARTILAGE OLIGOMERIC MATRIX PROTEIN ANGIOPOIETIN 1; RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; CAPILLARY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOTHELIUM CELL; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NANOCOMPUTED TOMOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIBIA; UPREGULATION; VASCULARIZATION;

ABSORPTIOMETRY, PHOTON; ANIMALS; IMMUNOHISTOCHEMISTRY; OSTEOGENESIS; OSTEOGENESIS, DISTRACTION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIBIA;

EID: 77951257275     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.02.004     Document Type: Article

References (36)

1. Watson J.T. Distraction osteogenesis. J Am Acad Orthop Surg 2006, 14:S168-S174.
2. Li G., Simpson A.H., Kenwright J., Triffitt J.T. Effect of lengthening rate on angiogenesis during distraction osteogenesis. J Orthop Res 1999, 17:362-367.
3. Rowe N.M., Mehrara B.J., Luchs J.S., Dudziak M.E., Steinbrech D.S., Illei P.B., et al. Angiogenesis during mandibular distraction osteogenesis. Ann Plast Surg 1999, 42:470-475.
4. Carvalho R.S., Einhorn T.A., Lehmann W., Edgar C., Al-Yamani A., Apazidis A., et al. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 2004, 34:849-861.
5. Pacicca D.M., Patel N., Lee C., Salisbury K., Lehmann W., Carvalho R., et al. Expression of angiogenic factors during distraction osteogenesis. Bone 2003, 33:889-898.
6. Aronson J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop Relat Res 1994, 124-131.
7. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
8. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
9. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
10. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282:468-471.
11. Sato T.N., Qin Y., Kozak C.A., Audus K.L. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A 1993, 90:9355-9358.
12. De Palma M., Venneri M.A., Galli R., Sergi Sergi L., Politi L.S., Sampaolesi M., Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226.
13. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000, 6:460-463.
14. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
15. Cho C.H., Kammerer R.A., Lee H.J., Steinmetz M.O., Ryu Y.S., Lee S.H., et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 2004, 101:5547-5552.
16. Cho C.H., Kim K.E., Byun J., Jang H.S., Kim D.K., Baluk P., et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 2005, 97:86-94.
17. Cho C.H., Kammerer R.A., Lee H.J., Yasunaga K., Kim K.T., Choi H.H., et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci U S A 2004, 101:5553-5558.
18. Cho C.H., Sung H.K., Kim K.T., Cheon H.G., Oh G.T., Hong H.J., et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci U S A 2006, 103:4946-4951.
19. Kim W., Moon S.O., Lee S.Y., Jang K.Y., Cho C.H., Koh G.Y., et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 2006, 17:2474-2483.
20. Lee S., Kim W., Moon S.O., Sung M.J., Kim D.H., Kang K.P., et al. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant 2007, 22:396-408.
21. Sung H.K., Kim Y.W., Choi S.J., Kim J.Y., Jeune K.H., Won K.C., et al. COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice. Am J Physiol Endocrinol Metab 2009, 297:E402-E409.
22. Shin HY, Lee YJ, Kim HJ, Park CK, Kim JH, Wang KC, Kim DG, Koh GY, Paek SH Protective role of COMP-Ang1 in ischemic rat brain. J Neurosci Res 2009, 88:1052-1063.
23. Park B.H., Jang K.Y., Kim K.H., Song K.H., Lee S.Y., Yoon S.J., et al. COMP-angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats. Bone 2009, 44:886-892.
24. Shefelbine S.J., Simon U., Claes L., Gold A., Gabet Y., Bab I., et al. Prediction of fracture callus mechanical properties using micro-CT images and voxel-based finite element analysis. Bone 2005, 36:480-488.
25. Kasama T., Isozaki T., Odai T., Matsunawa M., Wakabayashi K., Takeuchi H.T., et al. Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-Α and interferon-γ Transl Res 2007, 149:265-273.
26. Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999, 103:1231-1236.
27. Suzuki T., Miyamoto T., Fujita N., Ninomiya K., Iwasaki R., Toyama Y., et al. Osteoblast-specific angiopoietin 1 overexpression increases bone mass. Biochem Biophys Res Commun 2007, 362:1019-1025.
28. Street J., Bao M., deGuzman L., Bunting S., Peale F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99:9656-9661.
29. Fang T.D., Salim A., Xia W., Nacamuli R.P., Guccione S., Song H.M., et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res 2005, 20:1114-1124.
30. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 2005, 95:445-453.
31. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
32. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999, 13:1025-1036.
33. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
34. Jeong BC, Kim HJ, Bae IH, Lee KN, Lee KY, Oh WM, Kim SH, Kang IC, Lee SE, Koh GY, Kim KK, Koh JT COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2- induced osteoblast differentiation and bone formation. Bone 2010, 46:479-486.
35. Bais M.V., Wigner N., Young M., Toholka R., Graves D.T., Morgan E.F., et al. BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone 2009, 45:254-266.
36. Jeon E.J., Lee K.Y., Choi N.S., Lee M.H., Kim H.N., Jin Y.H., et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem 2006, 281:16502-16511.